Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03488251
Title PK,PD, Safety and Tolerability of Multiple Dose Regimens of MT-3724 With Gemcitabine and Oxaliplatin for the Treatment of Patients With Relapsed/Refractory Diffuse Large B Cell Non-Hodgkin's Lymphoma
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Molecular Templates, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
UC Irvine Health / Chao Family Comprehensive Cancer Center Orange California 92868 United States Details
Sarcoma Oncology Santa Monica California 90403 United States Details
Innovative Clinical Research Institute Whittier California 90603 United States Details
Rush University Chicago Illinois 60612 United States Details
Indiana Blood and Marrow Transplantation Indianapolis Indiana 46237 United States Details
University of Maryland Greenebaum Comprehensive Cancer Center Baltimore Maryland 21201 United States Details
Duke Cancer Center Durham North Carolina 27710 United States Details
Good Samaritan Hospital Cincinnati Ohio 45220 United States Details
UT Southwestern Medical Center Clinical Research Dallas Texas 75390 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field